Clinical Trials
4
Active:3
Completed:1
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients
Phase 2
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- SynAgile Corporation
- Target Recruit Count
- 17
- Registration Number
- NCT04778176
- Locations
- 🇮🇹
San Raffaele Cassino, Cassino, Italy
🇮🇹Centro Parkinson, Policlinico Tor Vergata, Rome, Italy
🇮🇹IRCCS San Raffaele Pisana, Rome, Italy
News
No news found